None listed
Conditions
Interventions
Dietary Supplement : This randomized crossover trial includes 48 elite athletes. Participants are assigned to Group A or Group B according to the intervention sequence, and all participants receive bo
Sponsors
Korea National Sport University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: ? Male elite athletes aged 18 years or older who have voluntarily provided written informed consent to participate in the study. ? Individuals who have had no major illnesses within the past 6 months and are considered medically eligible to participate in the study. ? Individuals who are able to comply with the study procedures, including the assessment schedule and investigational product administration protocol, throughout the study period. ?Individuals who are able to communicate in Korean sufficiently to understand the explanation of the study procedures and potential risks.
Exclusion criteria
Exclusion criteria: ?Human Clinical Trial–Related ?Individuals who have not provided written informed consent to participate in the study. ?Individuals who have participated in another human clinical trial within the past 2–3 months. ?Medical Conditions and Health Status ?Individuals who have undergone surgery within the past 6 months. ?Individuals with significant chronic diseases or infectious diseases, including cardiovascular disease, liver or kidney disease, cancer, or hypertension. ?Individuals with thyroid disorders, gastrointestinal diseases, autoimmune diseases, or malabsorption syndrome. ?Individuals who are currently injured or undergoing medical treatment. ?Medication and Supplement Use ?Individuals currently taking medications that may affect carbohydrate or lipid metabolism, body weight, hormonal function, or immune function. ?Individuals currently taking medications that may influence the study outcomes, including immunosuppressants, nonsteroidal anti-inflammatory drugs (NSAIDs), or diuretics. ?Individuals who are currently consuming or have regularly consumed probiotic products within the past 3 months. ?Other ?Individuals with a history of allergy or adverse reactions to the investigational product or its components. ?Carriers of hepatitis B or hepatitis C virus. ?Individuals who are deemed unsuitable for participation based on the medical judgment of the Principal Investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exercise endurance time | — |
Secondary
| Measure | Time frame |
|---|---|
| VO2max;Lactate;Blood oxygen saturation (SpO2) | — |
Countries
Korea, Republic of
Contacts
Public Contactsangyong Lee
Korea National Sport University
Outcome results
None listed